that on their own and cannabis has really gained a lot of traction in larger discussions about pain management, for instance. “That’s significant. That certainly pushes us into the realm of a larger producer in this industry and it gives us a lot of latitude for growth and expansion.” Anecdotal evidence shows that the use of cannabis can reduce the use of opioids, reduce the use of anti-psycho- tropic drugs, treat depression, and increase appetite. All of the different pharmaceuticals we’re prescribing are creating negative interactions and setting limitations rather than managing symptoms and treating people like cannabis can. I understand that Weed MD has become a licensed producer and retailer of cannabis oil as well, Bruce. BD-S: We just got our sales licence for cannabis oil in July and I can imagine as we move forward that it’s a part of this business that will grow exponentially. For a lot of patients, and that includes seniors, they’d like to use the oil instead of smoking cannabis.
Getting that sales licence for oil is a huge milestone for us.
For the seniors market, our goal was always to move toward extracting the medicinal oils from the cannabis plant. To be able to provide specialty oils means more patients, more seniors, will experience the benefits of medical cannabis. Between growing over 60 different strains of dried cannabis, harvesting those plants and now extracting medicinal oils, you must have a very diverse team at Weed MD. BD-S: Absolutely. We have grown our team in the last year from about six people to 60 – and I suspect by July 2018,
SPOTLIGHT ON BUSINESS MAGAZINE • DECEMBER 2018 136
Made with FlippingBook Annual report